Compare · 3 funds side by side · dividends reinvested

XOVR, EKG and MDEV

XOVRER Shares×EKGFirst Trust×MDEVFirst Trust×

Story of the three · Growth5Y$10,000 five years agoDividends reinvested · all three on one scale$9,263MDEV · best of the three

02 / 04

XOVR, EKG and MDEV, Ranked

Today

FundFeeYieldYTD1 year3 yrs · yr5 yrs · yrWorst dropVolatilityAssetsAvg rank

First Trust Nasdaq Lux Digital Health Solutions ETFUS Stock Styles · Large cap0.65%0.00%+29.2%+32.4%+26.5%[…]−22.1%25.1%$9M1.4

First Trust Indxx Medical Devices ETFSectors · Health care0.70%0.09%+11.0%+14.2%+10.6%−1.5%−18.2%17.3%$3M1.5

ERShares Private-Public Crossover ETFUnsorted0.75%0.00%+0.7%−5.0%[…][…]−23.1%25.4%$1.4B2.8

Rank among the three1st → 3rdFee, drop and volatility: lower ranks higherAvg rank: mean of the 8 ranks · 1 is best

End-of-day Nov 4, 2026 · returns include dividends · since: XOVR 2017 · EKG 2022 · MDEV 2021

Head to Head

Swap sides Versus in desk

Head to Head

ERShares Private-Public Crossover ETF · $1.4B[…]

XOVR

EKG

First Trust Nasdaq Lux Digital Health Solutions ETF · $9M[…]

$10,000 five years ago, dividends reinvested · they hold 13.3% in common

XOVRMeasureEKG

+0.7%Year to dateJan 1 → Nov 4+29.2%

−5.0%1 yearTotal return+32.4%

[…]3 years · per year$10,000 became […] · $20,264+26.5%

[…]5 years · per year[…]

0.75%Expense ratio$75 · $65 a year on $10k · lower is better0.65%

0.00%Trailing 12-mo yield$0 · $0 a year on $10k0.00%

−23.1%Worst dropSmaller is better−22.1%

25.4%VolatilityLower is calmer25.1%

XOVREKG Winner of the row, in its colourEach row: the bigger of the two fills its side

0–5EKG wins

End-of-day Nov 4, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns

More Ways to See the Pairs

XOVR vs EKG: Top 5 Holdings

Today

XOVR

26.9%in top 5

EKG

in top 539.8%

XOVRStockEKG

9.2%NVDAnot top 5

not top 5NTRA9.0%

not top 5ISRG8.7%

not top 5VEEV7.9%

not top 5IQV7.5%

not top 5DXCM6.8%

5.2%GOOGLnot top 5

4.5%METAnot top 5

4.3%CARTnot top 5

3.7%TOSTnot top 5

Held in common13.3%

End-of-day Nov 4, 2026 · share of each fund

XOVR vs EKG Returns, Every Period

ER SharesXOVR

−5.0%

past year

EKGFirst Trust

+32.4%

past year

XOVREKGFaded: behind in that period

0–2EKG wins

End-of-day Nov 4, 2026 · dividends in · faded = behind in that period

Unsorted vs Sector: XOVR vs MDEV

YTD

ER SharesXOVR

+0.7%

MDEVFirst Trust

+11.0%

+0.7%Year to date+11.0%

−23.1%Worst drop · 1Y−18.2%

25.4%Volatility · 1Y17.3%

0.0%Yield0.1%

$1.4BAssets$3.3M

4–0MDEV wins

End-of-day Nov 4, 2026 · smaller drop and lower volatility win

Cost, Income and Risk

Fees: XOVR, EKG, MDEV

Today

0.65%lowest, EKG

FundExpense ratioFee$10k

EKG0.65%$65

MDEV0.70%$70

XOVR0.75%$75

End-of-day Nov 4, 2026 · fee on $10,000 a year

Yields: XOVR, EKG, MDEV

0.09%highest, MDEV

FundTrailing yieldYield$10k

MDEV0.09%$9

XOVR0.00%$0

EKG0.00%$0

End-of-day Nov 4, 2026 · trailing 12-month yield

Income After Fees on $10,000

−$61most kept, MDEV

MDEV$9 − $70 = −$61

EKG$0 − $65 = −$65

XOVR$0 − $75 = −$75

KeptFee

End-of-day Nov 4, 2026 · yield in dollars minus the fee

Overlap: XOVR, EKG, MDEV

Today

13.3%most shared, XOVR and EKG

XOVREKGMDEV

XOVR—13.3%3.9%

EKG13.3%—12.1%

MDEV3.9%12.1%—

End-of-day Nov 4, 2026 · share held in common · outlined: the pair in versus

Return vs Bumpiness: 3 ETFs

+32.4%EKG, at 25.1% volatility

MDEVWorst drop−18.2%17.3% vol

EKGWorst drop−22.1%25.1% vol

XOVRWorst drop−23.1%25.4% vol

End-of-day Nov 4, 2026 · up and left is better

Paid More vs Made More

YTD

MDEVEKG

+11.0%Year to date+29.2%

0.1%Yield0.0%

+14.2%Past year+32.4%

0.70%Fee0.65%

3–1EKG wins

End-of-day Nov 4, 2026

Popular Pairs Near These Three

SCHD vs VIG

YTD

SchwabSCHD

+35.3%

VIGVanguard

+16.4%

+35.3%Year to date+16.4%

2.9%Yield1.4%

$121BAssets$109B

2–0SCHD wins

End-of-day Nov 4, 2026

JEPQ vs JEPI

YTD

J.P. MorganJEPQ

+8.5%

JEPIJ.P. Morgan

+8.8%

+8.5%Year to date+8.8%

12.2%Yield7.8%

$41.8BAssets$46.0B

1–1level

End-of-day Nov 4, 2026

SPYM vs SPY

YTD

SPDRSPYM

+13.4%

SPYSPDR

+13.3%

+13.4%Year to date+13.3%

1.0%Yield1.0%

$185BAssets$798B

1–0SPYM wins

End-of-day Nov 4, 2026